drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   

Week of Mon, Mar 24th, 2014

Sandoz launches generic version of Prevpac

Sandoz Inc. has rolled out lansoprazole capsules, amoxicillin capsules and clarithromycin tablets, a generic version of the combination medicine Prevpac from Takeda Pharmaceuticals.

Alli is recalled by GlaxoSmithKline

After issuing an alert yesterday, GlaxoSmithKline Consumer Healthcare is voluntarily recalling all alli weight-loss products from U.S. and Puerto Rico retailers.

Dr. Reddy's releases Caduet generic

Dr. Reddy's Laboratories has launched amlodipine besylate and atorvastatin calcium tablets in the U.S. market.

Roscoe Medical, Carex Health Brands to merge

Roscoe Medical and Carex Health Brands plan to merge, creating a leading manufacturer, marketer and distributor of home health care products.

Perrigo to roll out store-brand versions of Ensure nutritional drinks

The nutritionals business of Perrigo Co. plc is partnering with KanPak LLC to manufacture store-brand adult nutritional drinks, comparable to Ensure products.

Actavis, Valeant cleared to market Metronidazole 1.3%

Actavis plc and Valeant Pharmaceuticals International Inc. have received approval from the Food and Drug Administration for Metronidazole 1.3% Vaginal Gel, an antibiotic for the treatment of bacterial vaginosis (BV).

GSK issues alert on alli product tampering

GlaxoSmithKline has issued a warning to consumers that some bottles of its alli over-the-counter weight-loss aid have been subject to tampering.

New CEO to take helm at Crossmark

Ben Fischer, president and chief operating officer at Crossmark, has been named to succeed chief executive officer Joe Crafton, who is retiring after 26 years at the company.

Frito-Lay unveils new Lay's, Rold Gold snacks

Frito-Lay North America has added new varieties to its Lay's potato chip and Rold Gold pretzel brands.

Boldface Group names new chief executive

John LaBonty has been appointed president and chief executive officer at Boldface Group Inc., a celebrity beauty licensing company,

Coty appoints supply chain executive

Mario Reis has been hired as executive vice president of supply chain at Coty Inc.

Moberg launches new formulation of Kerasal Nail

Moberg Pharma AB this week plans to begin shipping a new patent-pending formulation of its Kerasal Nail fungal nail product to U.S. consumers.

Xolair from Genentech, Novartis cleared by FDA

The Food and Drug Administration has approved Xolair (omalizumab), a medication jointly developed by Genentech and Novartis for the treatment of chronic idiopathic urticaria (CIU), a form of chronic hives.